Inventor · disambiguated record
Philippe Halfon
Also filed as: HALFON PHILIPPE
8 granted patents·4 pending applications·22 citations·filing 2003–2024
79Inventor score
Files withGENOSCIENCE PHARMA5DENTALMED PHARM HOLDING LTD2HALFON PHILIPPE2COURCAMBECK JEROME1GENOSCIENCE1
Top patents by PatentIndex Score
12 records- 0188US8575195B2Treatment of hepatitis C virus related diseases using hydroxychloroquine or a combination of hydroxychloroquine and an anti-viral agentHALFON PHILIPPE·Filed 2013·Granted Nov 5, 2013·12 cites·12 claims
- 0279US8987302B2Treatment of hepatitis C virus related diseases using hydroxychloroquine or a combination of hydroxychloroquine and an anti-viral agentPANMED LTD·Filed 2012·Granted Mar 24, 2015·8 cites·7 claims
- 0357US2025074885A1Crystalline freebase form of 2-(4-chlorobenzylamino)-4-(4-tert-butylaminopiperidin-1-yl)-quinoline and uses thereofGENOSCIENCE PHARMA·Filed 2024·Application pending·0 cites
- 0456US10179770B2Quinolines derivatives as novel anticancer agentsGENOSCIENCE PHARMA·Filed 2014·Granted Jan 15, 2019·1 cites·29 claims
- 0556US8729014B2Specific HCV NS3 protease inhibitorsCOURCAMBECK JEROME·Filed 2011·Granted May 20, 2014·1 cites·20 claims
- 0647US2016279043A1Combinations of n-acetyl cysteine derivatives and cranberry polyphenols in compositions and methods for preventing and treating periodontal diseases and peri-implatitisDENTALMED PHARM HOLDING LTD·Filed 2014·Application pending·0 cites
- 0747US2019216704A1Combinations of n-acetyl cysteine derivatives and cranberry polyphenols in compositions and methods for preventing and treating periodontal diseases and peri-implatitisDENTALMED PHARM HOLDING LTD·Filed 2019·Application pending·0 cites
- 0845US8912141B2Treatment of hepatitis C virusHALFON PHILIPPE·Filed 2012·Granted Dec 16, 2014·0 cites·16 claims
- 0945US2006142204A1Pyrrolidine derivatives for use in treating heaptitis c virus infectionGENOSCIENCE·Filed 2003·Application pending·0 cites
- 1034US11261189B2Substituted 2,4 diamino-quinoline as new medicament for fibrosis, autophagy and cathepsins B (CTSB), L (CTSL) and D (CTSD) related diseasesGENOSCIENCE PHARMA·Filed 2019·Granted Mar 1, 2022·0 cites·36 claims
- 1130US10577362B2Substituted 2, 4-diamino-quinoline derivatives for use in the treatment of proliferative diseasesGENOSCIENCE PHARMA·Filed 2017·Granted Mar 3, 2020·0 cites·31 claims
- 1223US10722505B2Substituted 2,4 diamino-quinoline as new anticancer agentsGENOSCIENCE PHARMA·Filed 2015·Granted Jul 28, 2020·0 cites·24 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →